Genome editing using CRISPR, CAST, and Fanzor systems
- PMID: 38909984
- PMCID: PMC11278801
- DOI: 10.1016/j.mocell.2024.100086
Genome editing using CRISPR, CAST, and Fanzor systems
Abstract
Genetic engineering technologies are essential not only for basic science but also for generating animal models for therapeutic applications. The clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein (Cas) system, derived from adapted prokaryotic immune responses, has led to unprecedented advancements in the field of genome editing because of its ability to precisely target and edit genes in a guide RNA-dependent manner. The discovery of various types of CRISPR-Cas systems, such as CRISPR-associated transposons (CASTs), has resulted in the development of novel genome editing tools. Recently, research has expanded to systems associated with obligate mobile element guided activity (OMEGA) RNAs, including ancestral CRISPR-Cas and eukaryotic Fanzor systems, which are expected to complement the conventional CRISPR-Cas systems. In this review, we briefly introduce the features of various CRISPR-Cas systems and their application in diverse animal models.
Keywords: Clustered regularly interspaced short palindromic repeats-associated protein; Clustered regularly interspaced short palindromic repeats-associated transposons; Fanzor; Genome editing; IscB; TnpB.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures



Similar articles
-
Biochemical reconstitution of a type I-B CRISPR-associated transposon.Methods Enzymol. 2025;712:55-79. doi: 10.1016/bs.mie.2025.01.042. Epub 2025 Feb 26. Methods Enzymol. 2025. PMID: 40121087
-
Shooting the messenger: RNA-targetting CRISPR-Cas systems.Biosci Rep. 2018 Jun 21;38(3):BSR20170788. doi: 10.1042/BSR20170788. Print 2018 Jun 29. Biosci Rep. 2018. PMID: 29748239 Free PMC article. Review.
-
Metagenomic discovery of CRISPR-associated transposons.Proc Natl Acad Sci U S A. 2021 Dec 7;118(49):e2112279118. doi: 10.1073/pnas.2112279118. Proc Natl Acad Sci U S A. 2021. PMID: 34845024 Free PMC article.
-
Editorial: Genome Editing Goes Beyond CRISPR with the Emergence of 'Bridge' RNA Editing.Med Sci Monit. 2024 Aug 1;30:e945933. doi: 10.12659/MSM.945933. Med Sci Monit. 2024. PMID: 39086277 Free PMC article.
-
CRISPR-Based Technologies: Impact of RNA-Targeting Systems.Mol Cell. 2018 Nov 1;72(3):404-412. doi: 10.1016/j.molcel.2018.09.018. Mol Cell. 2018. PMID: 30388409 Free PMC article. Review.
Cited by
-
Efforts to Downsize Base Editors for Clinical Applications.Int J Mol Sci. 2025 Mar 6;26(5):2357. doi: 10.3390/ijms26052357. Int J Mol Sci. 2025. PMID: 40076976 Free PMC article. Review.
-
Cell therapies for immune-mediated disorders.Front Med (Lausanne). 2025 Mar 26;12:1550527. doi: 10.3389/fmed.2025.1550527. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40206475 Free PMC article. Review.
-
Brief guide to Caenorhabditis elegans survival assays.Mol Cells. 2025 Aug;48(8):100232. doi: 10.1016/j.mocell.2025.100232. Epub 2025 May 26. Mol Cells. 2025. PMID: 40436148 Free PMC article. Review.
-
A brief guide for gene delivery to the brain using adeno-associated viral vectors.Mol Cells. 2025 Mar;48(3):100189. doi: 10.1016/j.mocell.2025.100189. Epub 2025 Feb 2. Mol Cells. 2025. PMID: 39904462 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous